Morley Ruth, Fewtrell Mary S, Abbott Rebecca A, Stephenson Terence, MacFadyen Una, Lucas Alan
Medical Research Council Childhood Nutrition Research Centre, Institute of Child Health, London, United Kingdom.
Pediatrics. 2004 Mar;113(3 Pt 1):515-21. doi: 10.1542/peds.113.3.515.
Many studies have shown that children born small for gestational age (SGA) are at a neurodevelopmental disadvantage. We have shown that nutrient enrichment of formula fed to term SGA infants improves their growth and hypothesized that it also would improve their neurodevelopmental outcome.
A randomized, controlled trial of standard term-infant (n = 147) or nutrient-enriched (n = 152) formula for the first 9 months. A reference group of 175 breastfed SGA infants was also recruited.
Subjects were recruited in 5 maternity hospitals in Cambridge, Nottingham, and Leicester, all in the United Kingdom.
Healthy, term infants (gestation: > or =37 weeks) with birth weight <10th centile.
Bayley mental and psychomotor scores at 18 months (primary) and developmental scores from Knobloch, Pasamanick, and Sherrard's developmental screening inventory at 9 months (secondary).
There was no significant intergroup difference in Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) scores at 18 months. However, at 9 months, children fed the enriched formula had a significantly lower developmental quotient (99.5 vs 102.0; 95% confidence interval [CI] for difference: -4.6, -0.4). A significant disadvantage was seen in girls (-5.1; 95% CI: -7.8, -2.4) but not in boys (0.9; 95% CI: -2.4, 4.2). Breastfed infants had significantly higher MDI and PDI scores at 18 months than formula-fed infants. Confounding factors accounted for approximately 34% of the observed association between breastfeeding and MDI score and none of the association between breastfeeding and PDI score.
The previously reported enhanced linear growth in SGA children fed enriched formula was not matched by a neurodevelopmental advantage. At 9 months, girls fed the enriched formula had a significant developmental disadvantage, although this was not seen at 18 months. Later follow-up will determine any long-term effects on health or development. Meanwhile, use of enriched formula for term SGA children should not be promoted. It seems that breastfeeding may be especially beneficial for neurodevelopment in children born SGA.
许多研究表明,小于胎龄儿(SGA)出生时在神经发育方面处于劣势。我们已经证明,给足月SGA婴儿喂养营养强化配方奶可促进其生长,并推测这也将改善他们的神经发育结局。
一项针对标准足月婴儿(n = 147)或营养强化(n = 152)配方奶的为期9个月的随机对照试验。还招募了175名母乳喂养的SGA婴儿作为参照组。
研究对象来自英国剑桥、诺丁汉和莱斯特的5家妇产医院。
健康的足月婴儿(孕周:≥37周),出生体重低于第10百分位数。
矫正年龄18个月时的贝利智力发育指数(MDI)和精神运动发育指数(PDI)评分(主要指标),以及9个月时Knobloch、Pasamanick和Sherrard发育筛查量表的发育评分(次要指标)。
18个月时,两组间贝利智力发育指数(MDI)或精神运动发育指数(PDI)评分无显著差异。然而,在9个月时,喂养营养强化配方奶的儿童发育商显著较低(99.5对102.0;差异的95%置信区间[CI]:-4.6,-0.4)。女孩存在显著劣势(-5.1;95% CI:-7.8,-2.4),而男孩则未出现(0.9;95% CI:-2.4,4.2)。母乳喂养的婴儿在18个月时的MDI和PDI评分显著高于配方奶喂养的婴儿。混杂因素约占母乳喂养与MDI评分之间观察到的关联的34%,但与母乳喂养和PDI评分之间的关联无关。
先前报道的喂养营养强化配方奶的SGA儿童线性生长加速,并未伴随神经发育优势。在9个月时,喂养营养强化配方奶的女孩存在显著的发育劣势,尽管在18个月时未观察到。后续随访将确定对健康或发育的任何长期影响。同时,不应推广给足月SGA儿童使用营养强化配方奶。母乳喂养似乎对SGA出生儿童的神经发育特别有益。